Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13304-13312
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13304
Table 1 Serum Spondin-2 expression in each group (mean ± SD)
| Group | n | Spondin-2 (μg/L) | F | P value |
| Cervical cancer group | 147 | 25.68 ± 7.11 | 105.790 | 0.000 |
| Benign group | 92 | 17.52 ± 5.76 | ||
| Control group | 86 | 14.16 ± 4.96 |
- Citation: Zhang LL, Lin S, Zhang Y, Yao DM, Du X. Serum Spondin-2 expression, tumor invasion, and antitumor immune response in patients with cervical cancer. World J Clin Cases 2022; 10(36): 13304-13312
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13304.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13304